Single Center Food Allergy Oral Immunotherapy Study
Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
The Primary Objective of the study is to develop a customized regimen for oral immunotherapy
that reflects what the subject is allergic in a clinically significant way (i.e., the
offending food allergen is defined as a food allergen with a positive skin test or positive
specific IgE and a positive DBPCFC). Therefore, the investigators prefer that both single and
multiple food allergy subjects are included in the study.